Liberum

Quick links to important sections

Liberum

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Liberum

What is Liberum? Defining the Medicinal Entity and Its Function

Property Description
Active Ingredient Meloxicam
Forms Available Tablets, Oral Suspension, Injectable Solution
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Specific Mechanism Preferential Cyclooxygenase-2 (COX-2) Inhibitor
Origin Synthetic (Oxicam derivative)

What Type of Medicine is Liberum?

Liberum is a pharmaceutical product containing the active ingredient Meloxicam. It is formally categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID), which signifies its role as a medication for addressing pain, fever, and inflammation. Meloxicam is a synthetic compound derived from the Oxicam chemical family. It functions as a preferential Cyclooxygenase-2 (COX-2) inhibitor, meaning it primarily focuses its inhibitory action on the enzyme isoform associated with inflammatory signaling.

Composition and Forms of the Liberum Preparation

The sole active pharmaceutical substance in Liberum is Meloxicam, establishing it as a single-ingredient product. As a preparation intended for systemic administration—designed to affect the entire body—it is manufactured in several standard dosage forms. These typically include oral preparations such as tablets and suspensions, as well as parenteral options like an injectable solution for delivery via intramuscular or intravenous routes. This multi-form presentation is a differentiating factor that allows the medication to be used in various clinical settings.

The General Purpose of Liberum (Symptomatic Relief)

The overarching purpose of Liberum is to provide symptomatic relief by modulating the body's inflammatory response. The medication works by decreasing the production of inflammatory mediators, which are chemicals responsible for signaling pain and promoting swelling. By performing its anti-inflammatory, analgesic, and antipyretic actions, Liberum helps to alleviate key manifestations of inflammation and discomfort.

Regulatory References

  1. Meloxicam: MedlinePlus Drug Information

What side effects are possible with Liberum?

Possible Side Effects and Safety Information

Official regulatory documents classify the safety profile of Liberum based on the frequency and type of adverse reactions observed, as well as specific safety restrictions mandated by government authorities.

Frequency-Classified Adverse Reactions

Adverse reactions are primarily associated with effects on the Nervous System and are often dose-related. The most frequent effects are generally observed at the start of treatment or following a dose increase.

Classification Examples of Reactions
Very Common Drowsiness, Sedation, Ataxia (impaired coordination), Confusion, Dizziness
Common Fatigue, Constipation, Nausea, Vomiting
Rare Blood dyscrasias (e.g., agranulocytosis), Paradoxical reactions (e.g., excitement, rage), Hepatic dysfunction

Serious Adverse Reactions and Restrictions

Government regulatory agencies require a Boxed Warning regarding the concomitant use of Liberum with opioids and other central nervous system (CNS) depressants (including alcohol). This combination significantly increases the risk of severe respiratory depression, profound sedation, coma, and death.

Liberum is formally classified as a Schedule IV Controlled Substance. This classification is due to the potential for abuse, as well as the risk of developing physical dependence and withdrawal symptoms upon abrupt discontinuation of continuous use.

Population-Specific Safety Considerations

  • Elderly and Debilitated Patients: These individuals are noted to be particularly susceptible to the CNS depressant effects, such as oversedation, confusion, and ataxia, and require careful monitoring.
  • Pediatric Patients: Use in patients under the age of six is generally restricted based on established safety data.

Contraindications

Liberum is contraindicated in patients with a known hypersensitivity to this class of medicine and in those with acute narrow-angle glaucoma.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Liberum (Meloxicam) is officially documented to initially present with common gastrointestinal symptoms such as nausea, vomiting, and epigastric pain, along with systemic effects like drowsiness and lack of energy. The primary risk, as outlined in regulatory information, is the potential for severe clinical sequelae. These serious outcomes may involve the gastrointestinal system (manifesting as bleeding, ulceration, or perforation), the renal system (potentially leading to acute renal failure), and the Central Nervous System (CNS) (which can include convulsions and coma). Regulatory documents specify that the elderly and patients with pre-existing cardiovascular or GI risk factors are at a greater risk of serious outcomes in an overdose scenario.

Emergency Actions and Management

Regulatory guidance mandates that individuals must seek immediate medical attention following a suspected overdose. The official instruction requires calling emergency services immediately if the affected person collapses, has a seizure, or cannot be awakened, or if there are signs of severe GI bleeding (e.g., bloody or tarry stools or bloody vomit). No specific antidote is known for Meloxicam overdose. Consequently, management is focused on providing symptomatic and supportive care, including the administration of activated charcoal within one to two hours of exposure to reduce systemic absorption, and potentially cholestyramine to accelerate drug elimination.

Therapeutic Uses of Liberum

What Liberum Treats: Main Uses and Benefits

Liberum is commonly used for symptomatic management in clinical settings that involve inflammatory or irritative states. It is commonly used for conditions involving episodic or fluctuating manifestations, such as the symptoms associated with Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis. It is applied across domains where additional symptomatic support is needed to address the core symptom cluster of joint pain, swelling, tenderness, and related stiffness.

Symptom Focus and Clinical Contexts

The medication is also relevant when supportive symptom management is appropriate during acute or disruptive episodes, such as managing acute pain and discomfort from musculoskeletal causes or post-operative pain in certain scenarios. It helps address groups of symptoms that may become intense or disruptive, and it offers symptomatic relief that assists with maintaining functional stability when symptoms become temporarily overwhelming. Liberum may be part of symptomatic management for children (ages two and older) with Juvenile Rheumatoid Arthritis (JRA).


Quick Fact: Relief for Joint Pain and Stiffness

  • Common Use: Management of chronic, daily discomfort and inflammation associated with arthritis.
  • Benefit: Contributes to improved day-to-day comfort and mobility during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus overview on Meloxicam

Eligibility and Restrictions for Use

Who can and cannot use Liberum? (Meloxicam Eligibility)

Official regulatory guidelines determine the patient populations eligible to use Liberum (meloxicam) and those who are strictly prohibited.

Contraindicated Populations (Prohibited Use)

Liberum is contraindicated and must not be used by patients with the following conditions or history, as stated in regulatory labels:

  • A known hypersensitivity to meloxicam, aspirin, or any other Nonsteroidal Anti-inflammatory Drug (NSAID).
  • A history of allergic-type reactions to NSAIDs, such as asthma, hives, or nasal polyps.
  • Use in the setting of Coronary Artery Bypass Graft (CABG) surgery.
  • Severe organ failure, including severe heart failure, severely impaired liver function, or severe non-dialyzed renal failure.
  • Active or recurrent peptic ulceration or gastrointestinal hemorrhage.
  • Pregnancy from 30 weeks gestation onward.

Age-Specific Eligibility and Conditional Use

Population Eligibility Status (Official Labeling)
Adults (18+ years) Approved for use.
Children ge 2 years Approved for Juvenile Rheumatoid Arthritis (JRA) for specific formulations.
Children < 2 years Use and safety are generally not established or recommended.
Older Adults Use requires caution and monitoring due to higher risk of gastrointestinal or cardiovascular issues.

Eligibility is further restricted by patient health status. For instance, those with advanced renal disease or dehydration/hypovolemia require careful management, and use is generally avoided or permitted only if the condition is corrected and monitored. Use during the first and second trimesters of pregnancy is restricted to the lowest effective dose for the shortest duration.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

Liberum’s official regulatory profile mandates specific restrictions regarding co-administration with other substances. It is contraindicated for the treatment of pain during the peri-operative period of Coronary Artery Bypass Graft (CABG) surgery. Co-administration with other NSAIDs or analgesic doses of Aspirin is not generally recommended due to a documented increase in the risk of serious gastrointestinal adverse events, including bleeding and ulceration.

Drug Clearance and Exposure

Liberum is documented to increase the plasma levels of certain co-administered medicines through pharmacokinetic interactions. This includes Lithium and Methotrexate, whose clearances are officially reduced, resulting in elevated exposure and potential toxicity. Additive pharmacodynamic risk is noted with Anticoagulants (like Warfarin), Antiplatelet Agents, and SSRIs/SNRIs, which together present an increased risk of bleeding due to combined effects.

Renal and Circulation Effects

A primary concern is the interaction with agents affecting blood pressure and renal function. Liberum may diminish the antihypertensive or diuretic effects of ACE Inhibitors, ARBs, and Diuretics. This combination is officially noted to carry a higher risk of worsening renal function, particularly in the elderly and in patients who are volume-depleted. Additionally, use with alcohol may increase the risk of gastrointestinal bleeding and ulceration. The oral suspension formulation is not recommended for co-administration with Sodium Polystyrene Sulfonate due to the documented risk of intestinal necrosis.

Mechanism of Action

Liberum (chlordiazepoxide) is a long-acting compound that functions as a positive allosteric modulator of the GABAA receptor complex, a key biological target within the central nervous system (CNS). The compound is lipophilic, facilitating its widespread distribution, with preferential accumulation in lipid-rich CNS regions.

Liberum binds specifically to a distinct allosteric site on the GABAA receptor—the benzodiazepine site. This interaction does not directly activate the receptor; rather, it modifies the receptor's conformation. This conformational change increases the frequency of chloride channel opening when the native inhibitory neurotransmitter, GABA (gamma-aminobutyric acid), binds to its orthosteric site.

The resulting amplified chloride influx hyperpolarizes the postsynaptic neuron's membrane, making the neuron less responsive to excitatory stimuli and effectively inhibiting neuronal firing across various CNS structures, including the limbic system and reticular formation. The system-level physiological consequence of this enhanced GABAergic inhibition is a generalized reduction in neuronal excitability throughout the CNS.

Dosage and Administration Information

Liberum is administered via two primary routes: oral for long-term symptomatic management and intravenous (IV) injection for acute, short-term pain episodes. The core principle for use across all routes and indications is to adhere to the lowest effective dose for the shortest duration required to achieve patient goals.

Dosage and Administration Protocol

The medication is administered strictly once daily (qDay), reflecting its pharmacological profile. For standard oral use in adults, the starting and maintenance dose is typically 7.5 mg. The established maximum oral daily dose for tablets is 15 mg, while specific capsule formulations have a limit of 10 mg. The intravenous formulation has a separate maximum limit of 30 mg per day.

Administration Principle Labeled Instruction
Oral Intake Condition May be taken with or without food. Oral suspension requires shaking before administration.
Intravenous Use Administered as a bolus over 15 seconds. Patient must be well-hydrated.
Population Adjustment Maximum oral dose is reduced to 7.5 mg for patients on hemodialysis. Use is generally not recommended in cases of severe hepatic or renal impairment.
Missed Dose Rule If a dose is missed, only the next scheduled dose should be taken at the regular time; do not take two doses.

It is a procedural necessity that different oral formulations are not interchangeable even if they appear to have the same milligram strength. Adherence to these specific instructions defines the standardized clinical use of Liberum.

Recent Clinical Evidence

Research evidence / Overview of Studies for Liberum

This section provides an overview of the official research and clinical studies conducted on the medicine Liberum (Meloxicam). It focuses on the types of evidence available for its studied applications, the specific outcomes that were measured, and what remains uncertain according to scientific bodies.


Evidence for Symptomatic Management in Osteoarthritis (OA)

Randomized Controlled Trials (RCTs) and other studies have explored Liberum's role in conditions like Osteoarthritis. These short-term and intermediate-duration studies were observed in Adults, including the Older Adult population, with confirmed OA. The research examined study outcomes related to physical discomfort, specifically joint stiffness, and measures of daily functioning or activity level (such as the WOMAC Index).

Studies monitored how outcomes evolved for physical discomfort and daily functioning when compared to control groups receiving a placebo. Information on the durability of outcomes from long-term use remains limited. There is limited information for long-term outcomes (beyond one year) from controlled studies.


Evidence for Symptomatic Management in Rheumatoid Arthritis (RA)

Research for conditions characterized by fluctuating manifestations like Rheumatoid Arthritis (RA) includes Randomized Controlled Trials (RCTs) and systematic reviews. These studies monitored Adults with confirmed RA over defined time intervals, typically around 12 weeks for outcome measurement and up to 18 months for observation. Researchers examined outcomes related to systemic or functional imbalance, specifically looking at activity using standardized tools like the ACR response criteria.

The research explored symptom patterns only; the evidence does not study the medicine's influence on the underlying course of the disease or its potential to prevent joint destruction. Data for long-term use relies on pooled analyses and observational settings, meaning certainty remains low for long-term data.


Studies in Juvenile Rheumatoid Arthritis (JRA) and Acute Pain

Active-Controlled Studies evaluated Liberum's use in pediatric patients (children aged 2 years and older) with JRA, monitoring outcomes related to functional imbalance over short-term periods. Separately, the use of the injectable solution was evaluated in controlled trials for acute or disruptive episodes in Adult patients after specific surgical procedures, monitoring perceived discomfort and the requirement for supplemental opioid medication.


Research Gaps and Areas of Scientific Uncertainty

  • Long-term data are not fully established for use beyond one to two years, as follow-up durations were limited in the primary controlled trials.
  • Data for certain groups remain insufficient, particularly for patients with multiple concurrent health conditions (comorbidities).
  • The evidence quality varies across studies; research does not determine whether an individual will respond similarly to the group patterns observed in the trials.

Frequently Asked Questions (FAQ)

Common questions about Liberum (FAQ)


Q: How long does it typically take to see the expected effects of Liberum?

Clinical studies have indicated that for some conditions, a clinical response (relief of symptoms) was observed within three to four days of starting treatment. When taking multiple oral doses, steady-state concentrations—meaning consistent levels of the medicine in the body—are generally reached by approximately the fifth day of use.


Q: Do the side effects of Liberum usually go away over time?

Regulatory information indicates that many adverse reactions, such as common gastrointestinal issues, often manifest within the first week of treatment. Official reports indicate that in many instances, these initial effects were transient, suggesting they may stop or disappear after treatment is discontinued.


Q: Can I take Liberum if I am already taking over-the-counter pain relief?

Official documents do not generally recommend combining Liberum with other nonsteroidal anti-inflammatory drugs (NSAIDs) or analgesic (pain-relieving) doses of aspirin. This restriction is due to an elevated risk of serious gastrointestinal problems, such as bleeding. Non-NSAID, over-the-counter pain relievers are not specifically mentioned in the official prohibitions. However, all potential co-administered medicines are subject to healthcare provider review.


Q: What happens if I miss a dose of Liberum?

If a dose is missed, regulatory instructions strictly advise that you only take the next scheduled dose at its regular time. Regulatory instructions emphasize that you should not take two doses together to compensate for the missed one, as this may increase the risk of side effects.


Q: Does Liberum interact with common supplements like vitamins or herbal remedies?

The official product information primarily focuses on interactions with prescription medications. However, some supplements with blood-thinning properties (such as Ginkgo biloba or garlic) are described as potentially increasing the risk of bleeding when used with this class of medicine.


Q: Can Liberum affect my ability to drive or operate machinery?

Official documents contain warnings that patients should be cautious when performing activities that require alertness, such as driving or operating machinery. This caution is necessary because common side effects listed include drowsiness, sedation, confusion, and dizziness.


Q: What do clinical trial results say about Liberum?

Clinical trials for conditions like osteoarthritis and rheumatoid arthritis monitored outcomes related to physical discomfort (e.g., joint stiffness) and measures of daily functioning. Studies examined outcomes related to symptomatic relief for the signs and symptoms of these conditions and reported favorable results, as measured by standardized criteria.


Q: Are there dietary restrictions listed in official Liberum information?

Official information states that the oral formulation may be taken with or without food. While there is a known interaction risk with alcohol, regulatory documents do not list other specific restrictions on common foods or beverages.


Q: Can Liberum be used for conditions other than the main approved use?

Official prescribing information only defines the medication’s approved uses, known as therapeutic indications. The documents do not include information about any unapproved or 'off-label' conditions.


Q: What is the difference between Liberum and other similar prescription drugs?

Liberum is formally defined as a Nonsteroidal Anti-inflammatory Drug (NSAID). Its function is further specified as a preferential Cyclooxygenase-2 (COX-2) Inhibitor. This specific pharmacological class and mechanism of action help distinguish it from other categories of pain and inflammation relief medicines.


Q: Is Liberum a controlled substance?

Yes, Liberum is formally classified by regulatory agencies as a Schedule IV Controlled Substance. This classification is based on its potential for abuse and the risk of physical dependence.


Q: What is the risk of dependence or withdrawal with Liberum?

Due to its status as a Schedule IV Controlled Substance, the regulatory classification notes that stopping the medication abruptly after continuous use is associated with the possibility of withdrawal symptoms and the risk of physical dependence.


Q: Are there any long-term health concerns associated with using Liberum?

Official warnings note that the risk of serious side effects, including cardiovascular events (such as heart attack or stroke) and gastrointestinal problems (bleeding or ulcers), may increase with the duration of use.


Q: Does Liberum cause issues with fertility?

Official documents state that the use of this class of medicine (NSAIDs) may potentially impair female fertility by causing a reversible delay in ovulation. This effect suggests that discontinuation of the medicine may be a topic for discussion by individuals who are having difficulty conceiving.


Q: Is Liberum covered by most insurance plans?

While government programs like Medicare generally don't cover outpatient prescription drugs unless a patient has an elective drug plan, the coverage for Liberum ultimately depends on the individual insurance plan's formulary (list of covered medicines). Reviewing the specific plan’s formulary is necessary for determining coverage.


Q: Does Liberum cause weight changes?

Official documents list fluid retention and edema (swelling) as a potential adverse reaction associated with the medication. This retention of fluid can lead to a manifestation of rapid weight gain.


Q: How long does Liberum stay in a person's system after the last use?

Official pharmacokinetic information indicates that the drug has a mean elimination half-life (t1/2) ranging from approximately 15 to 20 hours in adults. This means it takes this amount of time for half the medicine to be eliminated, with the body clearing the medication and its metabolites through urine and feces over a longer period.


Q: Is there a generic version of Liberum available?

The active ingredient in Liberum is Meloxicam. The Food and Drug Administration (FDA) has officially determined that generic versions containing Meloxicam may be approved and marketed, which indicates that generic formulations may be available.


Q: Is Liberum available in countries outside of the USA?

Yes, the active ingredient (Meloxicam) is regulated by multiple government health authorities globally, including the European Medicines Agency (EMA), Health Canada, and the Therapeutic Goods Administration (TGA) in Australia. This indicates the active ingredient’s regulatory status and potential availability in various countries outside of the USA.


Q: What is the duration of treatment generally mentioned for Liberum?

For all uses, the overarching official principle is to use the lowest effective dose for the shortest duration necessary to achieve the patient's individual treatment goals. For acute (short-term) pain episodes, official documents advise that use is often not recommended to exceed one month.

How should Liberum be stored and disposed of?

Official Storage and Handling Requirements

Regulatory documents mandate that Liberum (Meloxicam) must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with protection from excessive heat. It is critical to keep the medicine from freezing. The medication must be kept in its original, tightly closed container and stored in a dry place, protected from direct light.

Child Safety and Disposal

Consistent with official labeling, Liberum must always be stored out of the reach and sight of children. To ensure safety and environmental protection, unused or expired medicine must not be disposed of via household trash or wastewater. Disposal should follow local pharmaceutical waste requirements, often requiring return to a pharmacy or authorized collection point, as advised by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Liberum found in:

A-Z Index: